NPS PHARMACEUTICALS INC Interest Expense
NPS PHARMACEUTICALS INC reported Interest Expense of $13.73 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-02-18
- NPS PHARMACEUTICALS INC interest expense for the quarter ending 2014-12-31 was $2.68M, a 5.14% increase year-over-year.
- NPS PHARMACEUTICALS INC interest expense for the quarter ending 2014-09-30 was $3.36M, a 13.69% increase year-over-year.
- NPS PHARMACEUTICALS INC interest expense for the quarter ending 2014-06-30 was $3.65M, a 20.24% increase year-over-year.
- NPS PHARMACEUTICALS INC interest expense for the quarter ending 2014-03-31 was $4.04M, a 18.85% increase year-over-year.
- NPS PHARMACEUTICALS INC interest expense for fiscal 2014 was $13.73M, a 14.99% increase from fiscal 2013.
- NPS PHARMACEUTICALS INC interest expense for fiscal 2013 was $11.94M, a 34.40% decline from fiscal 2012.
- NPS PHARMACEUTICALS INC interest expense for fiscal 2012 was $18.20M, a 51.78% decline from fiscal 2011.
- NPS PHARMACEUTICALS INC interest expense for fiscal 2011 was $37.74M, a 16.38% decline from fiscal 2010.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $6.04M derived: sum of 2 quarters · filed 2015-02-18 | $9.69M derived: sum of 3 quarters · filed 2015-02-18 | $13.73M 10-K · filed 2015-02-18 |
| 2014-09-30 | $3.36M 10-Q · filed 2014-11-10 | $7.01M derived: sum of 2 quarters · filed 2014-11-10 | $11.05M 10-Q · filed 2014-11-10 | $13.60M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-06-30 | $3.65M 10-Q · filed 2014-08-06 | $7.68M 10-Q · filed 2014-08-06 | $10.23M derived: sum of 3 quarters · filed 2015-02-18 | $13.19M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-03-31 | $4.04M 10-Q · filed 2014-05-08 | $6.58M derived: sum of 2 quarters · filed 2015-02-18 | $9.54M derived: sum of 3 quarters · filed 2015-02-18 | $12.58M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $5.51M derived: sum of 2 quarters · filed 2015-02-18 | $8.54M derived: sum of 3 quarters · filed 2015-02-18 | $11.94M 10-K · filed 2015-02-18 |
| 2013-09-30 | $2.96M 10-Q · filed 2014-11-10 | $5.99M derived: sum of 2 quarters · filed 2014-11-10 | $9.39M 10-Q · filed 2014-11-10 | $13.14M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $3.03M 10-Q · filed 2014-08-06 | $6.43M 10-Q · filed 2014-08-06 | $10.18M derived: sum of 3 quarters · filed 2015-02-18 | $14.63M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $3.40M 10-Q · filed 2014-05-08 | $7.15M derived: sum of 2 quarters · filed 2015-02-18 | $11.59M derived: sum of 3 quarters · filed 2015-02-18 | $16.06M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $8.20M derived: sum of 2 quarters · filed 2015-02-18 | $12.66M derived: sum of 3 quarters · filed 2015-02-18 | $18.20M 10-K · filed 2015-02-18 |
| 2012-09-30 | $4.44M 10-Q · filed 2013-11-06 | $8.91M derived: sum of 2 quarters · filed 2013-11-06 | $14.45M 10-Q · filed 2013-11-06 | $21.03M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $4.47M 10-Q · filed 2013-08-08 | $10.00M 10-Q · filed 2013-08-08 | $16.59M derived: sum of 3 quarters · filed 2014-02-18 | $27.18M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $5.53M 10-Q · filed 2013-05-09 | $12.12M derived: sum of 2 quarters · filed 2014-02-18 | $22.71M derived: sum of 3 quarters · filed 2014-02-18 | $33.04M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $17.18M derived: sum of 2 quarters · filed 2014-02-18 | $27.50M derived: sum of 3 quarters · filed 2014-02-18 | $37.74M 10-K · filed 2014-02-18 |
| 2011-09-30 | $10.59M 10-Q · filed 2012-11-09 | $20.92M derived: sum of 2 quarters · filed 2012-11-09 | $31.15M 10-Q · filed 2012-11-09 | $40.99M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $10.33M 10-Q · filed 2012-08-01 | $20.56M 10-Q · filed 2012-08-01 | $30.40M derived: sum of 3 quarters · filed 2013-02-21 | $41.14M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $10.23M 10-Q · filed 2012-05-03 | $20.07M derived: sum of 2 quarters · filed 2013-02-21 | $30.81M derived: sum of 3 quarters · filed 2013-02-21 | $42.02M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $20.58M derived: sum of 2 quarters · filed 2013-02-21 | $31.79M derived: sum of 3 quarters · filed 2013-02-21 | $45.13M 10-K · filed 2013-02-21 |
| 2010-09-30 | $10.74M 10-Q · filed 2011-11-03 | $21.95M derived: sum of 2 quarters · filed 2011-11-03 | $35.29M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $11.21M 10-Q · filed 2011-08-02 | $24.55M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $52.63M 10-K · filed 2012-02-15 |